The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达出“报告期结果不代表公司当前实际运营状况”这一观点。管理层是否反复或实质性地表明,刚报告的数字描述的公司已经被当前业务超越? 分析要点: - 管理层是否强调当前业务活动(如新业务、投资、定价)已超越报告期数字? - 是否有具体实例表明报告期未包含当前已在进行中的业务? - 管理层是否指出报告期成本对应未来收益? 在记录中,Rob Berkley多次提到: - “the table has been set for what is likely going to be a very strong balance of 2022”以及“2023, 2024”的展望。 - 投资组合方面,新钱收益率比账面收益率高100个基点,暗示未来收益将提升。 - 关于损失率,提到“paid loss ratio”改善,但强调这是历史数据。 - 关于增长,提到“submission flow”强劲,但未明确说报告期未反映当前业务。 但管理层是否明确说“报告期数字已经过时”?他们更多是展望未来,而非说报告期数字不代表当前。例如,他们提到“we are already benefiting from the discipline”但未说报告期未包含当前业务。 关键点:管理层是否指出“报告期内的业务活动已经落后于当前”?例如,他们提到“new money rate”高于账面收益率,但这是投资组合的当前状态,并非说报告期数字未反映。他们提到“we are not banking on positive reserve developments”但未说报告期数字过时。 整体上,管理层是在报告强劲业绩并展望未来,但并未明确说“报告期数字不代表当前业务”。他们提到“the table has been set”但这是对未来的展望,而非对报告期数字的否定。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.